Risk of severe hypoglycemia with newer second-line glucose-lowering medications in older adults with type 2 diabetes stratified by known indicators of hypoglycemia risk.

Phyo Than Htoo Julie M Paik Ethan M Alt Dae Hyun KimDeborah J WexlerSeoyoung C KimElisabetta Patorno

Published in: The journals of gerontology. Series A, Biological sciences and medical sciences (2023)

SGLT2i was associated with a lower hypoglycemia risk vs. incretin-based medications, with larger associations in patients using baseline insulin or sulfonylurea.

Keyphrases

type diabetes
glycemic control
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
blood glucose
peritoneal dialysis
physical activity
early onset
drug induced